Common Contracts
11 similar null contracts by Cerecor Inc., Eightco Holdings Inc., Epicept Corp, others
Eightco Holdings Inc. Up to $2,000,000 of Common Stock AT-THE-MARKET ISSUANCE SALES AGREEMENTEightco Holdings Inc. • April 25th, 2024 • Short-term business credit institutions • New York
Eightco Holdings Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Univest Securities, LLC, as selling agent (the “Agent”), shares of common stock, par value $0.001 per share, of the Company (the “Common Stock”), having an aggregate offering price of up to US$2,000,000 of Common Stock (the Common Stock subject to this At-The-Market Issuance Sales Agreement (this “Agreement”) being referred to herein as the “Shares”) on terms set forth herein and subject to the limitations set forth in Section 2(a) hereof. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
MGO Global Inc. Up to $1,650,000 Shares of Common Stock Equity Distribution AgreementMGO Global Inc. • February 8th, 2024 • Apparel & other finishd prods of fabrics & similar matl • New York
MGO Global Inc., a Delaware corporation (the "Company"), proposes to issue and sell through Maxim Group LLC (the "Agent"), as exclusive sales agent, shares of common stock, par value $0.00001 per share ("Common Stock"), of the Company (the "Shares") having an aggregate offering price of up to $1,650,000 on terms set forth herein. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
EuroDry Ltd. Up to $6,680,000 Common Shares Equity Distribution AgreementEuroDry Ltd. • October 11th, 2023 • Water transportation • New York
EuroDry Ltd., a Marshall Islands corporation (the “Company”), proposes to issue and sell through A.G.P./Alliance Global Partners (the “Agent”), as sales agent, common shares, par value $0.01 per share (“Common Shares”), of the Company having an aggregate offering price of up to $6,680,000 on terms set forth herein (the “Shares”). The Shares consist entirely of authorized but unissued Common Shares to be issued and sold by the Company.
fingermotion, inc. Up to $25,000,000 of Common Stock AT-THE-MARKET ISSUANCE SALES AGREEMENTFingerMotion, Inc. • September 11th, 2023 • Services-prepackaged software • New York
FingerMotion, Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Univest Securities, LLC, as selling agent (the “Agent”), shares of common stock, par value $0.0001 per share, of the Company (the “Common Stock”), having an aggregate offering price of up to US$25,000,000 of Common Stock (the Common Stock subject to this At-The-Market Issuance Sales Agreement (this “Agreement”) being referred to herein as the “Shares”) on terms set forth herein and subject to the limitations set forth in Section 2(a) hereof. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
Tenon Medical, Inc. Up to $6,700,000 Shares of Common Stock Equity Distribution AgreementTenon Medical, Inc. • May 4th, 2023 • Surgical & medical instruments & apparatus • New York
Tenon Medical, Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as exclusive sales agent, shares of common stock, par value $0.001 per share (“Common Stock”), of the Company (the “Shares”) having an aggregate offering price of up to $6,700,000 on terms set forth herein. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
Vivopower International PLC Up to $20,000,000 of Ordinary Shares Equity Distribution AgreementVivoPower International PLC • November 12th, 2021 • Electric & other services combined • New York
Vivopower International PLC, a public limited company incorporated under the laws of England and Wales (the “Company”), proposes to issue and sell through A.G.P./Alliance Global Partners (the “Agent”), as sales agent, ordinary shares, nominal value $0.012 per share (“Ordinary Shares”), of the Company having an aggregate offering price of up to $20,000,000 on terms set forth herein (the “Shares”). The Shares consist entirely of authorized but unissued Ordinary Shares to be issued and sold by the Company.
Hall of Fame Resort & Entertainment Company Up to $50,000,000 of Shares of Common Stock Equity Distribution AgreementHall of Fame Resort & Entertainment Co • October 1st, 2021 • Services-miscellaneous amusement & recreation • New York
Hall of Fame Resort & Entertainment Company, a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (“Maxim”) and Wedbush Securities Inc. (“Wedbush”), as sales agents, up to an aggregate of $50,000,000 of shares of common stock, par value $0.0001 per share (“Common Stock”), of the Company (the “Shares”) on terms set forth herein. Maxim and Wedbush may be referred to herein individually as an “Agent” and shall be collectively referred to herein as the “Agents”. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
Cerecor Inc. Up to $12,075,338 Common Stock Equity Distribution AgreementCerecor Inc. • January 27th, 2017 • Pharmaceutical preparations • New York
Cerecor Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as exclusive sales agent, shares of common stock, par value $0.001 per share (“Common Stock”), of the Company (the “Shares”) having an aggregate offering price of up to $12,075,338 on terms set forth herein. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
Viking Therapeutics, Inc. 3,748,726 Shares of Common Stock Equity Distribution AgreementViking Therapeutics, Inc. • June 20th, 2016 • Pharmaceutical preparations • New York
Viking Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as sales agent, up to an aggregate of 3,748,726 shares of common stock, par value $0.00001 per share (“Common Stock”), of the Company (the “Shares”) on terms set forth herein. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
Hemispherx Biopharma, Inc. 32,000,000 Shares of Common Stock Par Value $0.001 per Share Equity Distribution AgreementHemispherx Biopharma Inc • May 28th, 2010 • Biological products, (no disgnostic substances) • New York
Hemispherx Biopharma, Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as sales agent, up to 32,000,000 shares (the “Shares”) of Common Stock, $0.001 par value per share, of the Company (the “Common Stock”) on terms set forth herein. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
EpiCept Corporation Common Stock Equity Distribution AgreementEpicept Corp • February 11th, 2010 • Pharmaceutical preparations • New York
EpiCept Corporation, a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as sales agent, shares of Common Stock, $0.0001 par value per share (the “Common Stock”), of the Company having an aggregate offering price of up to $15,000,000 (the “Shares”) on terms set forth herein. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
